Entero Healthcare Solutions Ltd - Stock Valuation and Financial Performance

The company was incorporated as “Entero Healthcare Solutions Private Limited” as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Thereafter, the company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of its Shareholders held on August 7, 2023, and consequently, the name of the company was changed to ‘Entero Healthcare Solutions Limited’, and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.

The company was founded in 2018 by Prabhat Agrawal, its Promoter, Managing Director and Chief Executive Officer, and Prem Sethi, its Promoter, Whole-time Director and Chief Operating Officer, with the vision to create an organized, pan-India, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem. The company adds value to the healthcare product manufacturers that work with it by providing them reach and accessibility to pharmacies, hospitals and clinics through its integrated and technology driven, pan-India healthcare products distribution platform. As of September 30, 2023, its 77 warehouses located across the country, last-mile delivery infrastructure and relationships with pharmacies, hospitals and clinics enables healthcare product manufacturers to make their products available to a wide range of customers. Similarly, the pharmacies, hospitals and clinics that its service get access to a wide range of healthcare products through its distribution infrastructure and its healthcare product manufacturer relationships.

Business area of the company

Entero Healthcare Solutions is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. It offers demand generation solutions to healthcare product manufacturers by promoting and creating awareness of their product brands to healthcare professionals, doctors and channels such as pharmacies, hospitals (both private and government), clinics and customers through e-commerce marketplaces. Further, it provides end-to-end healthcare products distribution solutions including imports, central warehousing, redistribution, last mile delivery and connection with the pharmacies, hospitals and clinics. Its demand generation and demand fulfilment solutions are integrated across the value chain and it benefit from synergies arising from its wide customer network, distribution infrastructure and geographic reach. The company’s scale of operations allows it to procure products at competitive prices and has a wide product range with adequate inventory levels. It also provides a diverse spectrum of healthcare products, including pharmaceutical products, nutraceuticals, medical devices, surgical consumables, over-the-counter medicines and vaccines, which enables it to become a one stop shop for its customer’s healthcare product needs. 

Key awards, accreditations, and recognition

• 2021: The company received an award for the Best Healthcare Brand of 2021 from Economic Times.
• 2021: Vasavi Medicare Solutions Private Limited received Sambandh Award 20-21 from Sun Pharma.
• 2021: Galaxystar Pharma Distributors Private Limited received Sambandh Award 20-21 from Sun Pharma.
• 2021: Millennium Medisolutions received an award for outstanding contribution in the year 2020- 21 from Alkem Laboratories Limited.
• 2022: Chethana Pharma Private Limited received a certificate of appreciation for a great year of business collaboration by Merck India Healthcare.
• 2022: Vasavi Medicare Solutions Private Limited was recognised as Maximizer 2022 by Pfizer.
• 2022: Vasavi Medicare Solutions Private Limited received a certificate of recognition for winning E Miles 2022 Program from FDC Limited.
• 2023: Chethana Pharma Private Limited received a certificate of appreciation for its outstanding performance for FY 2022-2023, from Mankind Pharma Limited.
• 2023: Chethana Pharma Private Limited was recognised for outstanding and dedicated performance for the year 2022-2023 by JB Chemicals.
• 2023: Millennium Medisolutions Private Limited received a certificate of appreciation for its outstanding performance in FY 2022-2023 from Mankind Pharma Limited. 

Major events and milestones

• 2018: The company was incorporated in January 2018.
• 2018: Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.
• 2018: Acquired Novacare Healthcare Solutions Private Limited, which was the company’s first acquisition.
• 2019: Crossed monthly turnover of Rs 1000 million.
• 2020: Achieved positive EBITDA in the company’s second year of being operational.
• 2020: Entered into first promotion, marketing and distribution partnership with Roche Products (India) Private Limited.
• 2022: Acquired SS Pharma Traders Private Limited, which was its 32nd acquisition.
• 2023: Acquired Entero R.S. Enterprises Limited and Dhanvanthri Super Speciality Private Limited.